Evidence should precede digital-health scale
Scaling weakly evaluated tools can spread inequity, workflow burden or clinical error faster than benefit.
FUURAA original conceptual visualWhat the evidence indicates
A concise reading of the source
Scaling weakly evaluated tools can spread inequity, workflow burden or clinical error faster than benefit.
FUURAA interpretation
Why this could matter
Deployment milestones should be tied to outcome, safety and equity evidence.
How to read this signal
A direction still taking shape
Multiple developments point in this direction, but timing, adoption and outcomes remain open.



